Action Alert: Protect Access to Compounded Peptides Federal regulators are making decisions right now that could determine the future of peptide based therapies in the U.S. Compounded peptides such as BPC 157 and epitalon FDA Proposes Exclusion of Semaglutide, Tirzepatide, Liraglutide from 503B Bulks List FDA posted on the topic LinkedIn BPC 157 and the Difference Between an Evidence Gap and a Cover Up: What the entire human evidence base actually looks like, and the questions to ask next. WellFounded Founders Health & The FDA just put peptides like BPC 157, TB 500, and KPV on the clock. , As a compounding pharmacist, this is literally my world and most people dont understand the regulatory nuance behind what The peptide problem: Hype is outrunning the evidence FDA Compliance for Peptide Therapy and BPC 157 Holt Law